Insight into the Quality of Life of Patients with Ankylosing Spondylitis: Real-World Data from a US-Based Life Impact Survey

被引:0
作者
James T. Rosenbaum
Lisa Pisenti
Yujin Park
Richard A. Howard
机构
[1] Oregon Health & Science University,
[2] Legacy Devers Eye Institute,undefined
[3] UCB,undefined
[4] Inc.,undefined
[5] Novartis Pharmaceuticals Corporation,undefined
[6] Spondylitis Association of America,undefined
来源
Rheumatology and Therapy | 2019年 / 6卷
关键词
Ankylosing spondylitis; Epidemiological monitoring; Patient-reported outcomes; Quality of life; Qualitative research;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:353 / 367
页数:14
相关论文
共 162 条
  • [11] Oldroyd J(2015)Metabolic syndrome and chronic arthritis: effects of anti-TNF-α therapy Clin Exp Med 15 433-261
  • [12] Schachna L(2012)Diagnosis and classification in spondyloarthritis: identifying a chameleon Nat Rev Rheumatol 8 253-2034
  • [13] Buchbinder R(2015)Similarities and differences in the experience of fatigue among people living with fibromyalgia, multiple sclerosis, ankylosing spondylitis and stroke J Clin Nurs 24 2023-371
  • [14] Bremander A(2015)Chronic pain affects the whole person—a phenomenological study Disabil Rehabil 37 363-191
  • [15] Petersson IF(2012)Talk of frustration in the narratives of people with chronic pain Chronic Ill 8 176-1776
  • [16] Bergman S(2016)Ankylosing spondylitis diagnosis in US patients with back pain: identifying providers involved and factors associated with rheumatology referral delay Clin Rheumatol 35 1769-663
  • [17] Englund M(2005)Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care Ann Rheum Dis 64 659-545
  • [18] Shen CC(2006)Early diagnosis of spondyloarthritis Nat Clin Pract Rheumatol 2 536-11
  • [19] Hu LY(2006)The burden of ankylosing spondylitis J Rheumatol Suppl 78 4-1252
  • [20] Yang AC(2017)Perceptions of patients with rheumatic diseases on the impact on daily life and satisfaction with their medications: RHEU-LIFE, a survey to patients treated with subcutaneous biological products Patient Prefer Adherence 11 1243-483